LoginRegister
    FDA approves first treatment for  rare vasculitis in childrenFDA approves first treatment for  rare vasculitis in children
    Groundbreaking study-High-risk patients may not require long-term aspirin after PCIGroundbreaking study-High-risk patients may not require long-term aspirin after PCI
    Ceftolozane/tazobactam potential new treatment for serious nosocomial pneumonia: LancetCeftolozane/tazobactam potential new treatment for serious nosocomial pneumonia: Lancet
    Among other benefits, Hormone therapy may decrease incidence of diabetes in womenAmong other benefits, Hormone therapy may decrease incidence of diabetes in women
    Lung Ultrasound a reliable and efficient beside diagnostic tool for detecting ARDS, finds studyLung Ultrasound a reliable and efficient beside diagnostic tool for detecting ARDS, finds study
    Modify risk rather than merely relying on blood sugar lowering drugs in diabetes: DECLARE-TIMIModify risk rather than merely relying on blood sugar lowering drugs in diabetes: DECLARE-TIMI
    Vigorous exercise once or twice a week may lower mortality in stable CADVigorous exercise once or twice a week may lower mortality in stable CAD
    EMA approves gilteritinib for relapsed or refractory acute myeloid leukaemia in adultsEMA approves gilteritinib for relapsed or refractory acute myeloid leukaemia in adults
    Noninvasive nerve stimulation may relieve vertigo in vestibular migraineNoninvasive nerve stimulation may relieve vertigo in vestibular migraine
    In black children with uncontrolled asthma, stepping up inhaled glucocorticoids beneficialIn black children with uncontrolled asthma, stepping up inhaled glucocorticoids beneficial
    Arthritis drug could provide relief for lichen planus skin rash in future, finds studyArthritis drug could provide relief for lichen planus skin rash in future, finds study
    PILONIDAL SINUS, an agonising and discomforting disease- Dr Kapil DevPILONIDAL SINUS, an agonising and discomforting disease- Dr Kapil Dev
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X